These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
320 related items for PubMed ID: 14966870
1. Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA). Takamura Y, Ikeda H, Kanaseki T, Toyota M, Tokino T, Imai K, Houkin K, Sato N. Glia; 2004 Mar; 45(4):392-405. PubMed ID: 14966870 [Abstract] [Full Text] [Related]
2. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines. Goodwin BL, Xi H, Tejiram R, Eason DD, Ghosh N, Wright KL, Nagarajan U, Boss JM, Blanck G. Cell Growth Differ; 2001 Jun; 12(6):327-35. PubMed ID: 11432807 [Abstract] [Full Text] [Related]
4. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene. Rohn W, Tang LP, Dong Y, Benveniste EN. J Immunol; 1999 Jan 15; 162(2):886-96. PubMed ID: 9916712 [Abstract] [Full Text] [Related]
5. IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes. Dong Y, Rohn WM, Benveniste EN. J Immunol; 1999 Apr 15; 162(8):4731-9. PubMed ID: 10202014 [Abstract] [Full Text] [Related]
6. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice. Xu Y, McDonald J, Perloff E, Butticè G, Schreiber BM, Smith BD. Mol Immunol; 2007 Mar 15; 44(7):1709-21. PubMed ID: 16982097 [Abstract] [Full Text] [Related]
7. TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. Lee YJ, Han Y, Lu HT, Nguyen V, Qin H, Howe PH, Hocevar BA, Boss JM, Ransohoff RM, Benveniste EN. J Immunol; 1997 Mar 01; 158(5):2065-75. PubMed ID: 9036950 [Abstract] [Full Text] [Related]
8. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation. Li D, Qian L, Chen C, Shi M, Yu M, Hu M, Song L, Shen B, Guo N. J Immunol; 2009 Feb 15; 182(4):1799-809. PubMed ID: 19201831 [Abstract] [Full Text] [Related]
9. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells. Radosevich M, Song Z, Gorga JC, Ksander B, Ono SJ. Invest Ophthalmol Vis Sci; 2004 Sep 15; 45(9):3185-95. PubMed ID: 15326139 [Abstract] [Full Text] [Related]
10. Identification of distinct regions of 5' flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene. Piskurich JF, Wang Y, Linhoff MW, White LC, Ting JP. J Immunol; 1998 Jan 01; 160(1):233-40. PubMed ID: 9551976 [Abstract] [Full Text] [Related]
11. Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator. Radosevich M, Jager M, Ono SJ. Exp Mol Pathol; 2007 Feb 01; 82(1):68-76. PubMed ID: 16650406 [Abstract] [Full Text] [Related]
12. Differential expression of MHC class II molecules in highly metastatic breast cancer cells is mediated by the regulation of the CIITA transcription Implication of CIITA in tumor and metastasis development. Shi B, Vinyals A, Alia P, Broceño C, Chen F, Adrover M, Gelpi C, Price JE, Fabra A. Int J Biochem Cell Biol; 2006 Feb 01; 38(4):544-62. PubMed ID: 16343978 [Abstract] [Full Text] [Related]
13. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation. Meissner M, Whiteside TL, van Kuik-Romein P, Valesky EM, van den Elsen PJ, Kaufmann R, Seliger B. Br J Dermatol; 2008 May 01; 158(5):930-40. PubMed ID: 18284388 [Abstract] [Full Text] [Related]
14. Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells. Croce M, De Ambrosis A, Corrias MV, Pistoia V, Occhino M, Meazza R, Giron-Michel J, Azzarone B, Accolla RS, Ferrini S. Oncogene; 2003 Oct 30; 22(49):7848-57. PubMed ID: 14586411 [Abstract] [Full Text] [Related]
15. Induction of CIITA and modification of in vivo HLA-DR promoter occupancy in normal thymic epithelial cells treated with IFN-gamma: similarities and distinctions with respect to HLA-DR-constitutive B cells. Rigaud G, De Lerma Barbaro A, Nicolis M, Cestari T, Ramarli D, Riviera AP, Accolla RS. J Immunol; 1996 Jun 01; 156(11):4254-8. PubMed ID: 8666795 [Abstract] [Full Text] [Related]
16. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. Muhlethaler-Mottet A, Otten LA, Steimle V, Mach B. EMBO J; 1997 May 15; 16(10):2851-60. PubMed ID: 9184229 [Abstract] [Full Text] [Related]
17. CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells. Meissner M, Whiteside TL, Kaufmann R, Seliger B. Arch Dermatol Res; 2009 Feb 15; 301(2):189-93. PubMed ID: 19104823 [Abstract] [Full Text] [Related]
18. Impaired class II transactivator expression in mice lacking interferon regulatory factor-2. Xi H, Goodwin B, Shepherd AT, Blanck G. Oncogene; 2001 Jul 12; 20(31):4219-27. PubMed ID: 11464288 [Abstract] [Full Text] [Related]
19. Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells. Sartoris S, Tosi G, De Lerma Barbaro A, Cestari T, Accolla RS. Eur J Immunol; 1996 Oct 12; 26(10):2456-60. PubMed ID: 8898960 [Abstract] [Full Text] [Related]
20. Prolonged MHC class II expression and CIITA transcription in human keratinocytes. Takagi A, Nishiyama C, Kanada S, Niwa Y, Fukuyama K, Ikeda S, Okumura K, Ogawa H. Biochem Biophys Res Commun; 2006 Aug 25; 347(2):388-93. PubMed ID: 16836979 [Abstract] [Full Text] [Related] Page: [Next] [New Search]